Clene Provides Update on ALS Clinical Development Meeting With FDA

Go back to Clene Provides Update on ALS Clinical Development Meeting With FDA
(NASDAQ: CLNN) Delayed: 3.84 -0.04 (1.03%)
Previous Close $3.88    52 Week High $ 
Open $3.92    52 Week Low $ 
Day High $3.92    P/E N/A 
Day Low $3.78    EPS $ 
Volume 33,861